Pneumonia in the patient with chronic obstructive pulmonary disease.: Levels of severity and risk classification

被引:0
|
作者
de Oña, JMR
Fernández, MG
Celdrán, J
Puente-Maestu, L
机构
[1] Hosp Nuestra Senora Prado, Unidad Gest Clin Neumol, Talavera De La Reina, Toledo, Spain
[2] Univ Madrid, Hosp Gen Gregorio Maranon, Serv Neumol, Madrid 3, Spain
来源
ARCHIVOS DE BRONCONEUMOLOGIA | 2003年 / 39卷 / 03期
关键词
pneumonia; risk; COPD;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
OBJECTIVES: To analyze the severity, clinical course and mortality in patients with community-acquired pneumonia and COPD. METHOD: Retrospective study of patients admitted with pneumonia over a period of 12 months. From records, we gathered information related to patient characteristics, signs and symptoms and concomitant disease and classified each patient according to risk. RESULTS: One hundred twenty-nine patients with a mean age of 71.13 (SD 17) were identified; 43 (33.3%) had COPD with severe airflow obstruction (FEV1 937 mL, SD 309), although there were no differences from one risk classification to another. No significant differences were found in mortality, as 8 patients (18.6%) with COPD died and 9 patients (10.7%) without COPD. The length of hospital stay was similar in both groups. Patients with COPD suffered more severe pneumonia and were at higher risk (classes IV and V). The percentage of COPD patients using chronic domiciliary oxygen therapy who died (75%) was different from the percentage of such patients who lived (37%); percent mortality also differed by level of risk. Patients receiving oxygen therapy had greater obstruction and greater respiratory insufficiency upon admission (PaO2/FiO(2): 216.9, SID 41.92). CONCLUSIONS: The mortality rates and mean hospital stays of patients with and without COPD who are admitted with community-acquired pneumonia are similar, but patients with COPD suffer more severe pneumonia. Mortality is higher in patients with community-acquired pneumonia and COPD who are receiving domiciliary oxygen therapy and have greater airflow obstruction and respiratory deterioration upon admission.
引用
收藏
页码:101 / 105
页数:5
相关论文
共 50 条
  • [21] Inhaled corticosteroids might not increase the risk of pneumonia in patients with chronic obstructive pulmonary disease in Japan
    Hirano, Ryosuke
    Fujita, Masaki
    Matsumoto, Takemasa
    On, Rintaro
    Watanabe, Kentaro
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3503 - 3509
  • [22] Chronic obstructive pulmonary disease patients have a higher risk of occurrence of pneumonia by air pollution
    Ho, Shu-Chuan
    Chuang, Kai-Jen
    Lee, Kang-Yun
    Chen, Jen-Kun
    Wu, Sheng-Ming
    Chen, Tzu-Tao
    Lee, Chun-Nin
    Chang, Chih-Cheng
    Feng, Po-Hao
    Chen, Kuan-Yuan
    Su, Chein-Ling
    Tsai, Cheng-Yu
    Chuang, Hsiao-Chi
    SCIENCE OF THE TOTAL ENVIRONMENT, 2019, 677 : 524 - 529
  • [23] Risk Stratification in Chronic Obstructive Pulmonary Disease. Can the Spanish Guidelines be Improved?
    Golpe, Rafael
    Suarez-Valor, Maria
    Castro-Anon, Olalla
    Perez-de-Llano, Luis A.
    ARCHIVOS DE BRONCONEUMOLOGIA, 2018, 54 (10): : 533 - 535
  • [24] Is pain a risk factor for symptom severity in patients with chronic obstructive pulmonary disease?
    Ozsoy, Ismail
    Kahraman, Buse Ozcan
    Tanriverdi, Aylin
    Acar, Serap
    Alpaydin, Aylin Ozgen
    Sevinc, Can
    Savci, Sema
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [25] Blood eosinophilia in chronic obstructive pulmonary disease: impact on exacerbations risk and severity
    Laouini, Ines
    Zaibi, Haifa
    Ben Jmia, Emna
    Ouertani, Hend
    Ben Amar, Jihene
    Aouina, Hichem
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [26] Exhaled nitric oxide levels in exacerbations of asthma, chronic obstructive pulmonary disease and pneumonia
    Al-Ali, MK
    Howarth, PH
    SAUDI MEDICAL JOURNAL, 2001, 22 (03) : 249 - 253
  • [27] Evaluation of thyroid dysfunction in chronic obstructive pulmonary disease.
    Madhuri, Gupta
    Vardey, S. K.
    Nalin, Joshi
    Dixit, R.
    BIOMEDICAL RESEARCH-INDIA, 2013, 24 (01): : 110 - 113
  • [28] Pathophysiology of chronic obstructive pulmonary disease. Update 2006
    Groneberg D.A.
    Welte T.
    Der Pneumologe, 2006, 3 (2): : 89 - 97
  • [29] Physical Activity in Chronic Obstructive Pulmonary Disease. An Update
    Garcia-Aymerich, Judith
    ARCHIVOS DE BRONCONEUMOLOGIA, 2017, 53 (08): : 413 - 414
  • [30] Pathophysiology of chronic obstructive pulmonary disease. Update 2006
    Groneberg, D. A.
    Welte, T.
    PNEUMOLOGE, 2006, 3 (02): : 89 - 97